Migraine & Chronic Headache

Neurologist Lawrence Robbins, MD, discusses missed adverse events, flaws in FDA’s reporting system, and findings from his practice.

Lawrence Robbins, MD, contends that better methods are needed to capture a new drug’s full AE profile, using the new CGRP mAb class as an example.

Experts discuss the staggering stats and offer concrete advice from their own practices.

Clinicians can help patients recognize and cope with migraine triggers, including differentiating them from premonitory symptoms.

The device’s dual-use approval opens up new options for migraine care in adolescents and adult.

A review of chronic migraine management in special populations reveals prevalence and research gaps.

Migraine is now recognized as a disease with targeted treatments, meaning clinicians have more options in their toolbox.

A Q&A with neurologist Scott M. Friedenberg, MD, on common headache assessment and prescribing challenges, and how a new EMR tool may help physicians reduce referrals and lessen costs.